News and Events

FyoniBio collaborates with BioLamina and Alder Therapeutics

FyoniBio, Alder Therapeutics, and BioLamina enter Consortium Grant Agreement to Propel Recombinant Human Laminin Development for Clinical Applications.

FyoniBio gets CIR accreditation

We are pleased to announce that FyoniBio has received CIR (Crédit d’Impôt Recherche or CIR) accreditation for three years until 2025, which will benefit our French clientele.

Launch of FyoniBio’s CHOFlow® Technology

CHOFlow®: Our high yield expression technology for afucosylated ADCC enhanced antibodies and beyond.

Successful Cell Line Development for Strike Pharma

Strike Pharma and FyoniBio Conclude Successfully Cell Line Development of Strike’s Bi-specific Antibody and Clinical Lead Candidate.

Service Agreement with adivo

FyoniBio and adivo GmbH sign a Service Agreement covering the generation of a production cell line for their canine therapeutic mAb candidate

Cooperation with Strike Pharma

We have signed a Master Service Agreement with Strike Pharma covering the cell line development for a novel bi-specific therapeutic mAb.

Partnership with ProteoNic

We have signed a license agreement for using ProteoNic’s 2G Unic™ technology in our cell line development platform.

Launch of FyoniBio GmbH

The FyoniBio service branch of Glycotope GmbH will continue its business as FyoniBio GmbH.

Cooperation with BioGenes

BioGenes and FyoniBio begin a cooperation for Pharmacokinetic & Immunogenicity Analyses

Collaboration with CSL Behring

We are happy to have initiated a collaboration with CSL Behring research division.

German Biotechnology Days

Come and meet us at the German Biotechnology Days in Berlin. This event serves as a national forum for the German biotechnology industry, facilitating interactions between entrepreneurs, scientists, and partners from politics, funding institutions, and administration.

16 – 17 April 2024

Swiss Biotech Day 2024

Join FyoniBio at the Swiss Biotech Day on April 22nd and 23rd in Basel, Switzerland! Swiss Biotech Day stands as a flagship event in Europe’s biotechnology landscape, drawing professionals from across the global life sciences sector. In 2024, it continues its tradition of fostering networking, stimulating discussions, and showcasing breakthroughs in R&D, manufacturing, data management, and more.

22 – 23 April 2024

BioTalk US 2024

Attend the BioTalk US 2024, a yearly gathering which unites leaders, influencers, and senior executives from across the globe in Pharma & Biopharmaceutical Manufacturing. This exclusive event offers a prime opportunity to exhibit products and services to the pivotal decision-makers who are shaping the industry’s future.

7 – 8 May 2024